American Heart Journal
Volume 141, Issue 6 , Pages 908-914, June 2001

Hemodynamics as surrogate end points for survival in advanced heart failure: An analysis from FIRST☆☆☆★

Durham, NC, Chicago, Ill, Dommartin Les Toul, France, Galveston, Tex, and Chapel Hill, NC

FromaDuke Clinical Research Institute, Durham, NC;bNorthwestern Medical Center, Chicago, Ill;cHopital Jeanne d’Arc, Dommartin Les Toul, France; dUniversity of Texas at Galveston; and ethe University of North Carolina at Chapel Hill

Received 11 August 2000; accepted 16 February 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported in part by Glaxo-Wellcome, Research Triangle Park, NC.

☆☆ Reprint requests: Monica R. Shah, MD, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715. E-mail: shah0013@mc.duke.edu

★ Guest Editor for this manuscript was Robert O. Bonow, MD, Northwestern University Medical School, Chicago, Ill.

PII: S0002-8703(01)70016-6

doi:10.1067/mhj.2001.115299

American Heart Journal
Volume 141, Issue 6 , Pages 908-914, June 2001

Article Tools

* Image Usage & Resolution